These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37138290)

  • 1. NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology.
    Zavecz Z; Shah VD; Murillo OG; Vallat R; Mander BA; Winer JR; Jagust WJ; Walker MP
    BMC Med; 2023 May; 21(1):156. PubMed ID: 37138290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease.
    Lucey BP; McCullough A; Landsness EC; Toedebusch CD; McLeland JS; Zaza AM; Fagan AM; McCue L; Xiong C; Morris JC; Benzinger TLS; Holtzman DM
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation.
    Mander BA; Marks SM; Vogel JW; Rao V; Lu B; Saletin JM; Ancoli-Israel S; Jagust WJ; Walker MP
    Nat Neurosci; 2015 Jul; 18(7):1051-7. PubMed ID: 26030850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years.
    Winer JR; Mander BA; Kumar S; Reed M; Baker SL; Jagust WJ; Walker MP
    Curr Biol; 2020 Nov; 30(21):4291-4298.e3. PubMed ID: 32888482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats.
    Hector A; Provost C; Delignat-Lavaud B; Bouamira K; Menaouar CA; Mongrain V; Brouillette J
    Alzheimers Res Ther; 2023 Oct; 15(1):174. PubMed ID: 37833786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow Wave Sleep Is a Promising Intervention Target for Alzheimer's Disease.
    Lee YF; Gerashchenko D; Timofeev I; Bacskai BJ; Kastanenka KV
    Front Neurosci; 2020; 14():705. PubMed ID: 32714142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain.
    Winer JR; Mander BA; Helfrich RF; Maass A; Harrison TM; Baker SL; Knight RT; Jagust WJ; Walker MP
    J Neurosci; 2019 Aug; 39(32):6315-6324. PubMed ID: 31209175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermoneutral temperature exposure enhances slow-wave sleep with a correlated improvement in amyloid pathology in a triple-transgenic mouse model of Alzheimer's disease.
    Wang J; Huffman D; Ajwad A; McLouth CJ; Bachstetter A; Kohler K; Murphy MP; O'Hara BF; Duncan MJ; Sunderam S
    Sleep; 2024 Jun; 47(6):. PubMed ID: 38512801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Busatto GF; de Gobbi Porto FH; Faria DP; Squarzoni P; Coutinho AM; Garcez AT; Rosa PGP; da Costa NA; Carvalho CL; Torralbo L; de Almeida Hernandes JR; Ono CR; Brucki SMD; Nitrini R; Buchpiguel CA; Souza Duran FL; Forlenza OV
    Alzheimers Dement (Amst); 2020; 12(1):e12122. PubMed ID: 33426265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
    Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
    Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Effect of Education on Memory-Encoding Activation in Subjective Cognitive Decline.
    Mizuno A; Karim HT; Ly MJ; Cohen AD; Lopresti BJ; Mathis CA; Klunk WE; Aizenstein HJ; Snitz BE
    J Alzheimers Dis; 2021; 81(3):1065-1078. PubMed ID: 33843669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
    Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
    Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol.
    Moga DC; Beech BF; Abner EL; Schmitt FA; El Khouli RH; Martinez AI; Eckmann L; Huffmyer M; George R; Jicha GA
    Trials; 2019 Dec; 20(1):806. PubMed ID: 31888732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
    Sperling RA; Donohue MC; Rissman RA; Johnson KA; Rentz DM; Grill JD; Heidebrink JL; Jenkins C; Jimenez-Maggiora G; Langford O; Liu A; Raman R; Yaari R; Holdridge KC; Sims JR; Aisen PS
    J Prev Alzheimers Dis; 2024; 11(4):802-813. PubMed ID: 39044488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Farrell ME; Papp KV; Buckley RF; Jacobs HIL; Schultz AP; Properzi MJ; Vannini P; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA
    Neurology; 2022 Apr; 98(15):e1512-e1524. PubMed ID: 35338074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.